RAPT Therapeutics and Shanghai Jeyou Pharmaceutical Announce Positive Topline Data from Phase 2 Trial of RPT904 (JYB1904) in Chronic Spontaneous Urticaria GlobeNewswire October 20, 2025 – RPT904 at both Q8W and Q12W dosing showed comparable efficacy and safety to omalizumab at Q4W dosing– Efficacy sustained at Week 16 after a single dose of RPT904– Well […]

ProCap BTC to Appoint Renae Cormier as Chief Financial Officer GlobeNewswire October 20, 2025 â— Renae Cormier's extensive investment experience and proven expertise managing bitcoin as a balance sheet reserve asset strengthens ProCap BTC's financial leadership ahead of its proposed business combination with Columbus Circle Capital Corp I New York, NY, Oct. 20, 2025 (GLOBE

Aqua Metals Closes $13 Million Capital Raise with Prominent Institutional Investor, Company Poised to Accelerate Commercialization Strategy GlobeNewswire October 20, 2025 RENO, Nev., Oct. 20, 2025 (GLOBE NEWSWIRE) — Aqua Metals, Inc. (NASDAQ: AQMS), a pioneer in sustainable lithium battery recycling with its proprietary AquaRefining(TM) technology, today announced it has closed a $13 million registered

Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor(R) Functional Beverages Across New England Through Atlantic Importing Alliance GlobeNewswire October 20, 2025 WESTBROOK, Maine, Oct. 20, 2025 (GLOBE NEWSWIRE) — Synergy CHC Corp. (NASDAQ: SNYR), a leading consumer health and wellness company, today announced a strategic distribution partnership with Atlantic Importing Company, one of Southern New England's

Reverba Global Introduces ClinOps G.P.S.(TM) to Set a New Course for Clinical Trial Execution and Chart a Clearer Path from Protocol to Completion GlobeNewswire October 20, 2025 Comprehensive clinical operations navigation system aligns sponsors, CROs, investigators, sites and patients to improve trial planning, performance and outcomes Implementation with a top 15 global pharmaceutical company demonstrated

Two Posters at ESMO Congress 2025 Highlight Immutep's Focus on Changing Treatment Landscape in First Line Non-Small Cell Lung Cancer GlobeNewswire October 20, 2025 Novel combination of efti with KEYTRUDA(R) and chemotherapy generates strong response rates across all PD-L1 expression levels in first line non-small cell lung cancer (1L NSCLC) including 61.7% ORR in low

Volaris Group Acquires Fintilect GlobeNewswire October 20, 2025 TORONTO, Oct. 20, 2025 (GLOBE NEWSWIRE) — Volaris Group today announced the acquisition of the UK arm of Fintilect, a US and UK-based provider of front-end digital banking platforms. With 40 years of experience, Fintilect provides a modular, cloud-hosted suite of products which sit between the consumers

Heidelberg Materials North America strengthens footprint in British Columbia with acquisition of Island Aggregates This acquisition is the latest step in Heidelberg Materials' pure-play growth strategy in North America GlobeNewswire October 20, 2025 Irving, Texas, Oct. 20, 2025 (GLOBE NEWSWIRE) — Heidelberg Materials North America has acquired the assets and reserves of Island Aggregates, one

IDI Announces Integration with TazWorks to Expand Access to IDI's Best-in-Class Identity Intelligence in the Background Screening Industry GlobeNewswire October 20, 2025 BOCA RATON, Fla., Oct. 20, 2025 (GLOBE NEWSWIRE) — Interactive Data, LLC (“IDI”), a red violet company (NASDAQ: RDVT) and leader in identity verification and risk mitigation, today announced an agreement for a

Rubicon Organics Announces Health Canada Cultivation License For Cascadia (Hope, BC) Facility GlobeNewswire October 20, 2025 40% increase in cultivation capacity expected to drive revenue and EBITDA growth in Rubicon's premium cannabis products The Company also announces the naming of cultivation facilities to Pacifica (previously “Delta Facility”) and Cascadia (previously “Hope Facility”). VANCOUVER, British Columbia,